Market Overview

Global Coronary Stents Market size was valued at USD 10.10 Billion in 2023 and is poised to grow from USD 10.44 Billion in 2024 to USD 13.54 Billion by 2032, growing at a CAGR of 3.31 % in the forecast period (2024-2032).

The global coronary stents market is an important segment of cardiovascular medical devices, as the prevalence of cardiovascular diseases, including CAD and myocardial infarctions, increases steadily. A coronary stent is essentially a mesh tube that appears very small but has an expandable capacity. It is introduced through a catheter in a narrowed or blocked artery of a patient to restore normal blood flow to the heart. They have transformed the entire landscape of interventional cardiology interventions by decreasing the mere incidence of purely invasive surgical procedures such as CABG. Advances in technology involving stents-DES and bioresorbable vascular scaffolding-have improved outcomes in terms of patient care significantly by reducing the rates of restenosis and late complications considerably.

Increasing incidence of lifestyle disorders like diabetes, obesity, and hypertension coupled with aging populations have driven the need for coronary stents. Unhealthy lifestyles, diet, and smoking have accelerated the prevalence of CVDs, thereby driving more coronary interventions. Advances in healthcare infrastructure in emerging markets, and increasing adoption of minimally invasive procedure also spurred growth in this market. Today, coronary angioplasty, for example stenting, is often favoured since patients will be able to leave the hospital sooner and because recovery is faster.

Technological innovations have always paved the way for market innovations. Drug-eluting stents, coated with pharmacological agents that prevent undue tissue growth, are now considered to be the gold standard in PCI as compared to bare-metal stents. Moreover, bioresorbable stents, which gradually dissolve over time, also avoid the long-term risks of permanent implants and provide improved patient safety as well as clinical outcomes. Advanced polymers-based stents, thinner strut designs, and better biocompatibility are other research areas accelerating quickly.

The market is further driven due to rising R&D investments along with strategic agreements between medical device manufacturers and the healthcare providers. Leading players in the market have focused on innovation of new product launches with more improved performance along with durability. Besides, facilitation of suitable regulatory frameworks in different countries also through the positive reimbursement policies assists in market entry. Demand for coronary stents is also being fuelled by increased awareness among patients and healthcare professionals about the benefits of early diagnosis and treatment of CAD.

Despite this optimism, there are some issues in the market, such as the high price of advanced stents, price pressure, and risks associated with stent placement, including thrombosis, restenosis, and late stent failure. Moreover, strict regulatory procedures for new products may delay their launch. Nevertheless, the increased adoption of new technologies and continuous clinical trials for better stent performance are likely to overcome these challenges.

Key Findings:

• Over 60% of the world's 55 million dementia sufferers live in low- and middle-income countries. New cases occur around 10 million annually.
• Most often, dementia can be caused by numerous illnesses and traumas of the brain. The most common form of dementia is Alzheimer disease, accounting for 60-70% of cases.

Market Drivers

Increasing Adoption of Minimally Invasive Procedures

• The increasing demand for minimally invasive procedures also works as an imperative driver for the global market for coronary stents, owing to the variety of benefits compared with traditional open surgery. Such techniques include fewer incisions and minimal trauma that allows patients a relatively shorter time in recovery as opposed to that which is involved when using other types of open surgeries. Coronary stent placement through catheter-based techniques eliminates the need for open-heart surgeries such as CABG, which involve longer hospital stays and higher costs but with increased risks post-operatively.
• Imagers, guidewires, and catheter systems have added more improvements to the precision and success rate of these procedures, helping physicians treat more complex cases with better outcomes. Patients who undergo minimally invasive stent placement have less pain, less scarring, and a faster return to normal activities, resulting in higher satisfaction rates. Furthermore, the increasing global burden of cardiovascular diseases (CVDs), together with the enhanced need for effective and economical interventions, is driving these procedures further, and rising patient awareness among patients and improved access to interventional cardiology in emerging markets are increasingly fuelling these trends, placing minimally invasive techniques at the core of modern coronary care.

Key Findings:

• The BioFreedom Drug Coated Coronary Stent System received FDA approval in January 2023 for the treatment of patients who present with constriction of blood vessels due to coronary artery disease, but carry circumstances that make them at high risk of bleeding. To prevent re-narrowing, Biolimus A9 is infused into the stent and gradually eluted. Primary clinical studies of the BioFreedom stent have shown its ability to allow patients taking anticoagulants to stop one of them a month later without raising their risk of heart attack or death. This approvals now make the market for coronary stents more competitive and open new choices for patients as well as doctors.

Aging Global Population and Lifestyle-Related Health Issues

• The major drivers of the growth of the coronary stents market are the aging global population and the increasing prevalence of lifestyle-related health issues. As life expectancy increases, the elderly population is growing at a tremendous rate globally, and this demographic is especially prone to cardiovascular diseases (CVDs) such as coronary artery disease (CAD). Physiological changes in the cardiovascular system due to aging include arteriosclerosis and plaque deposition, leading to the occurrence of heart diseases. On a completely independent basis, lifestyle conditions in the modern era are characterized by sedentary lifestyles, unhealthy diets, smoking, and high stress levels, all of which have been associated with growing health problems, including obesity, hypertension, and diabetes. These rank as primary risk factors for CVDs and are increasingly being reported among younger generations.
• With increasing aging and lifestyle-related diseases, the incidence of coronary artery blockages has become higher, requiring more interventional treatments like stent placement. The increasing burden of these health challenges has heightened the demand for advanced medical solutions, including drug-eluting and bioresorbable stents, which can offer effective treatment with less invasion. Managing such trends is very important for healthcare systems worldwide because it enables them to effectively deal with the growing incidences of cardiovascular diseases while enhancing the wellbeing of patients.

Key Findings:

• People 60 years of age and older outnumbered children under the age of five in 2020.
• The percentage of people over 60 in the world will almost double, from 12% to 22%, between 2015 and 2050.

Market Opportunities

Favourable Reimbursement Policies and Government Initiatives

• Favoured reimbursement policies and government initiatives are one of the positive factors driving the global coronary stents market. In fact, the governments of various developed economies understand the increasing burden of cardiovascular disease and are taking positive steps to ensure that treatment becomes more accessible and affordable. Reimbursement policies for coronary interventions, including stent placement, reduce the cost burden on the patient and health care providers. This is boosting the usage of high-tech medical devices. In developed nations, such as the U.S., the European nations, and Japan, reimbursement packages for coronary stent procedures are available for a vast section of the population. Government initiatives such as public awareness campaigns, preventive screenings, and financing medical research have been additional factors in the adoption of coronary stents by the general population in developed nations.
• When governments absorb the cost of stent procedures via insurance and national healthcare plans, they ensure that timely and effective treatments are offered to the patients. This indirectly translates to better health outcomes, as well as lower long-term economic costs that are associated with untreated cardiovascular conditions. In other words, when the developing world has solid health infrastructures, similar reimbursement models would find a serious foothold, which would further boost the market.

Key Findings:

• The bread distribution program and the World Bank-sponsored social distribution program accounted for Af 2 billion and Af 12.7 billion of the approximately Af 14.7 billion social package.
• Transfers of around Af 1.3 billion to provinces for COVID-19 response
• More than Af 5.2 billion for the support of over agriculture and temporary employment with Af 1.0 billion, respectively.

Market Restraining Factors

Stringent Regulatory Approval Processes

• Regulatory approvals are the key restraint in the global coronary stents market as they take longer periods of time to get approvals, thereby slowing down the launching of new technology and raising costs for the manufacturer. Coronary stents must undergo clinical testing and clinical trials to be acceptable by regulatory authorities such as the U.S. Food and Drug Administration (FDA), the European Medicines Agency (EMA), and other national health authorities. The processes are created to ensure new stent designs, materials, and drug coatings are safe for use in patients, but are time-consuming and costly. Pre-market approval requires extensive testing and post-market surveillance and reporting make the development cycle more complex.
• The clinical effectiveness of the product must be proven, besides quality being validated according to specific requirements, and that again can call for rather substantial investment in R&D. Even though regulations are significant for patient safety, on the other hand, that very thing works as a challenge for companies who are looking to bring innovative stents to the market as fast as possible. On top of that, the approval time may differ with regions, leading manufacturers to walk through different regional regulatory landscapes in order to navigate the complexity of launching a new product. So, long lead times for getting approvals and more regulatory hurdles result in slowing innovation and market expansion, especially where the regulatory regimes are still changing in emerging economies.

Segmentation Analysis

The market scope is segmented because of by Stent Type, by Deployment, by End User.

• By Stent Type

Based on the Stent Type of the market is segmented into Drug-Eluting Stent, Bioresorbable Stent, Bare Metal Stent, Covered Stent, Others.

Drug-Eluting Stent (DES) segment dominated the global market of coronary stents among others. The drug eluting stent is in much preference due to their capacity of providing maximum inhibition to restenosis-the narrowing of the artery following the insertion of the stent. Such stents contain a drug on their outer cover which gets gradually released preventing an excess of tissue growth inside it. Tissue growth inside is a most common reason of re-narrowing after the stenting of bare metal stents. There has been a lot of demand for DES due to their superior clinical outcomes, mainly in terms of long-term efficacy and patient safety.

The supremacy of DES is given because these have a proven track record of treating coronary artery disease most effectively while minimizing complications. Since coronary artery disease remains the leading cause of death in the world, treatments that reduce follow-up procedures and enhance patient outcomes are crucial. DES have consistently shown less incidence of restenosis and thrombosis as compared to BMS, resulting in their overall acceptance.

• By Deployment

Based on the Deployment of the market is segmented into Self-expandable, Balloon-expandable.

The balloon-expandable stents have been the market leader in the global coronary stents market, primarily due to their wide usage in interventional cardiology and better performance in many clinical scenarios. The balloon-expandable stent is designed to be expanded by inflating a balloon catheter after the stent has been positioned at the site of blockage in the coronary artery. This mechanism ensures high precision deployment in addition to radially optimized strength, and is especially effective at treating coronary artery disease wherein successful treatment outcomes critically depend on accurate deployment.

They are preferred across a wide variety of clinical uses because of better flexibility and for the ability to adapt to anatomy in the case of the coronary artery, especially in smaller, tortuous structures. They typically are used within high-risk patient populations because this type of intervention offers consistent reliable expansion, a factor that further reduces the rates of restenosis and various complications. A proven clinical benefit combined with emerging technologies such as drug-eluting balloon-expandable stents keeps them at market leadership.

• Regional Snapshots

The developed healthcare structure of North America, high healthcare expenses, and wide facilities for contemporary medical technologies have positioned this region at the top of the global market for coronary stents. In general, there is a built-up health care system in the U.S., which covers most coronary stent procedures by Medicare and private health insurance programs. The high volume of interventions being performed in North America and the early adoption curve for new stent technologies, such as drug-eluting and bioresorbable stents, has contributed to this position. Indeed, several of the leading medical device manufacturers and research institutions continue to interact and innovate with new and improved stent technologies. This is further supplemented by the acknowledgement of cardiovascular disease and treatment options in this sector both by healthcare professionals and patients. The other market, most likely to gain speed rapidly is that of the coronary stent in the Asia-Pacific region.

Further factors driving it are lifestyle changes, among others such as poor diets, smoking, and sedentary behaviour, which have boosted the incidence rate of cardiovascular diseases and ageing population of countries like China and India. The rapid improvements in healthcare infrastructure and access to highly advanced medical treatments in emerging economies also contribute to market growth. Other major drivers of the region to grow at an accelerated pace include increased government spending on healthcare and an increasingly middle-class population with greater health care spending capacity. Asia-Pacific is also observing increased awareness of preventive cardiovascular care and access to minimally invasive procedures, thereby supporting the adoption of coronary stents.

List of Companies Profiled

• Abbott
• Medtronic
• Boston Scientific Corporation
• Terumo Corporation
• B Braun Melsungen AG
• Biotronik
• Stentys SA
• MicroPort Scientific Corporation
• R. Bard, Inc.
• Cook Medical

Key Industry Developments

• In February 2023, Abbott and Cardiovascular Systems, Inc. announced that Abbott would acquire CSI, a medical device company employing a revolutionary atherectomy technology to treat coronary artery disease and peripheral artery disease, definitively. Under the terms of the transaction, stockholders of CSI will receive $20 per common share, and the total equity value is estimated at $890 million.
• On June 18, 2024, Boston Scientific Corporation announced a definitive agreement to buy Silk Road Medical, Inc., a medical device company that has created a cutting-edge platform of products to prevent stroke in patients with carotid artery disease through a minimally invasive procedure called trans carotid artery revascularization or TCAR. The purchase price is about $27.50 per share and reflects an enterprise value of roughly $1.16 billion.

Report Coverage

The report will cover the qualitative and quantitative data on the Global Coronary Stents Market. The qualitative data includes latest trends, market players analysis, market drivers, market opportunity, and many others. Also, the report quantitative data includes market size for every region, country, and segments according to your requirements. We can also provide customize report in every industry vertical.

Report Scope and Segmentations

Global Coronary Stents Market Regional Analysis

North America accounted for the highest xx% market share in terms of revenue in the Coronary Stents market and is expected to expand at a CAGR of xx% during the forecast period. This growth can be attributed to the growing adoption of Coronary Stents. The market in APAC is expected to witness significant growth and is expected to register a CAGR of xx% over upcoming years, because of the presence of key Coronary Stents companies in economies such as Japan and China.

The objective of the report is to present comprehensive analysis of Global Coronary Stents Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language.

Coronary Stents Market Report is also available for below Regions and Country Please Ask for that

North America

• U.S.
• Canada

Europe

• Switzerland
• Belgium
• Germany
• France
• U.K.
• Italy
• Spain
• Sweden
• Netherland
• Turkey
• Rest of Europe

Asia-Pacific

• India
• Australia
• Philippines
• Singapore
• South Korea
• Japan
• China
• Malaysia
• Thailand
• Indonesia
• Rest Of APAC

Latin America

• Mexico
• Argentina
• Peru
• Colombia
• Brazil
• Rest of South America

Middle East and Africa

• Saudi Arabia
• UAE
• Egypt
• South Africa
• Rest Of MEA

Points Covered in the Report

• The points that are discussed within the report are the major market players that are involved in the market such as market players, raw material suppliers, equipment suppliers, end users, traders, distributors and etc.
• The complete profile of the companies is mentioned. And the capacity, production, price, revenue, cost, gross, gross margin, sales volume, sales revenue, consumption, growth rate, import, export, supply, future strategies, and the technological developments that they are making are also included within the report. This report analysed 12 years data history and forecast.
• The growth factors of the market are discussed in detail wherein the different end users of the market are explained in detail.
• Data and information by market player, by region, by type, by application and etc., and custom research can be added according to specific requirements.
• The report contains the SWOT analysis of the market. Finally, the report contains the conclusion part where the opinions of the industrial experts are included.

Key Reasons to Purchase

• To gain insightful analyses of the Coronary Stents market and have comprehensive understanding of the global market and its commercial landscape.
• Assess the production processes, major issues, and solutions to mitigate the development risk.
• To understand the most affecting driving and restraining forces in the market and its impact in the global market.
• Learn about the Coronary Stents market strategies that are being adopted by leading respective organizations.
• To understand the future outlook and prospects for the Coronary Stents market. Besides the standard structure reports, we also provide custom research according to specific requirements.

Research Scope of Coronary Stents Market

• Historic year: 2019- 2022
• Base year: 2023
• Forecast: 2024 to 2032
• Representation of Market revenue in USD Billion

Coronary Stents Market Trends: Market key trends which include Increased Competition and Continuous Innovations Trends: